STAT

Gawande says health venture is not seeking profits. But whose bottom line will it benefit?

Dr. Atul Gawande has described his new health care company as a “nonprofit” that will operate independently from the three massive corporations providing its funding — a firewall he said is crucial to ensuring its mission stays focused on the needs of patients.

But since he was named CEO in June, the three founders of the company — Amazon, JPMorgan Chase, and Berkshire Hathaway — have remained circumspect about the health venture’s precise legal structure, focus, and funding.

A person familiar with the inner-workings of the enterprise told STAT that its corporate creators

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Senate Probe Into Novo Pricing, A New UTI Antibiotic, And More
The U.S. Senate health committee is investigating the prices Novo Nordisk charges for its blockbuster medications Ozempic and Wegovy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT1 min read
STAT+: Nuclear Regulatory Commission Advisers Beset By Conflicts Of Interest, Report Finds
Advisers to the Nuclear Regulatory Commission, a U.S. government agency tasked with ensuring the safe use of radioactive materials, were beset by conflicts of interest, report finds

Related Books & Audiobooks